Home > News > Nanobac Life Sciences Announces Manufacturing Agreement
October 4th, 2004
Nanobac Life Sciences Announces Manufacturing Agreement
Abstract:
Nanobac Life Sciences, Inc. is pleased to announce the signing of a Manufacturing Agreement with Medicorp, Inc., for the production of two blood tests for the detection of Nanobacteria. Nanobac is transferring production of both the Nano-Capture ELISA assay and the Nano-Sero IgG ELISA assay from its Nanobac Oy research laboratory in Kuopio, Finland to Medicorp in preparation for FDA clinical
trials and expanded distribution.
Source:
prnewswire
Bookmark:
| Related Links |
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
Announcements
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||